The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The TIM3/Gal9 signaling pathway: An emerging target for cancer immunotherapy
Authors
Keywords
TIM3/Gal9, Immuno-oncology, Immune checkpoint receptors, Immune checkpoint blockade, Immune suppression
Journal
CANCER LETTERS
Volume 510, Issue -, Pages 67-78
Publisher
Elsevier BV
Online
2021-04-23
DOI
10.1016/j.canlet.2021.04.011
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Galectin-9 as a biomarker of disease severity
- (2021) Preeti Moar et al. CELLULAR IMMUNOLOGY
- Prognostic Impact of PD-1 and Tim-3 Expression in Tumor Tissue in Stage I-III Colorectal Cancer
- (2020) Wentao Kuai et al. Biomed Research International
- Tim-3/galectin-9 pathway and mMDSC control primary and secondary resistances to PD-1 blockade in lung cancer patients
- (2019) Emeric Limagne et al. OncoImmunology
- Lipopolysaccharide mediates time-dependent macrophage M1/M2 polarization through the Tim-3/Galectin-9 signalling pathway
- (2019) Wang Zhang et al. EXPERIMENTAL CELL RESEARCH
- Expression of the Tim3‐Galectin 9 axis is altered in drug‐induced maculopapular exanthema
- (2019) Ruben Fernandez‐Santamaría et al. ALLERGY
- Circulating levels of PD-L1 and Galectin-9 are associated with patient survival in surgically treated Hepatocellular Carcinoma independent of their intra-tumoral expression levels
- (2019) Kostandinos Sideras et al. Scientific Reports
- The Tim-3-Galectin-9 Pathway and Its Regulatory Mechanisms in Human Breast Cancer
- (2019) Inna M. Yasinska et al. Frontiers in Immunology
- Gal9/Tim-3 expression level is higher in AML patients who fail chemotherapy
- (2019) Paola Dama et al. Journal for ImmunoTherapy of Cancer
- Galectin-9: A Predictive Biomarker Negatively Regulating Immune Response in Glioma Patients
- (2019) Tingyu Liang et al. World Neurosurgery
- Significance of TIM3 expression in cancer: From biology to the clinic
- (2019) Cinzia Solinas et al. SEMINARS IN ONCOLOGY
- Molecular and immune correlates of TIM-3 (HAVCR2) and galectin 9 (LGALS9) mRNA expression and DNA methylation in melanoma
- (2019) Tobias A. W. Holderried et al. Clinical Epigenetics
- The co-expression characteristics of LAG3 and PD-1 on the T cells of patients with breast cancer reveal a new therapeutic strategy
- (2019) Huimin Du et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Expression profiles and clinical value of plasma exosomal Tim-3 and Galectin-9 in non-small cell lung cancer
- (2018) Jianwei Gao et al. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS
- TIM-3 Regulates CD103 + Dendritic Cell Function and Response to Chemotherapy in Breast Cancer
- (2018) Álvaro de Mingo Pulido et al. CANCER CELL
- Soluble Tim-3 and Gal-9 are associated with renal allograft dysfunction in kidney transplant recipients: A cross-sectional study
- (2018) Ya Mei Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Role of Galectins in Tumors and in Clinical Immunotherapy
- (2018) Feng-Cheng Chou et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Blockade of TIM3 relieves immunosuppression through reducing regulatory T cells in head and neck cancer
- (2018) Jian-Feng Liu et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Lck promotes Zap70-dependent LAT phosphorylation by bridging Zap70 to LAT
- (2018) Wan-Lin Lo et al. NATURE IMMUNOLOGY
- DNA methylation and repressive H3K9 and H3K27 trimethylation in the promoter regions of PD-1, CTLA-4, TIM-3, LAG-3, TIGIT, and PD-L1 genes in human primary breast cancer
- (2018) Varun Sasidharan Nair et al. Clinical Epigenetics
- Galectin-9 is an easy to measure biomarker for the interferon signature in systemic lupus erythematosus and antiphospholipid syndrome
- (2018) Lucas L van den Hoogen et al. ANNALS OF THE RHEUMATIC DISEASES
- Tim-3 expression and its role in hepatocellular carcinoma
- (2018) Feifei Liu et al. Journal of Hematology & Oncology
- Serum galectin-9 as a noninvasive biomarker for the detection of endometriosis and pelvic pain or infertility-related gynecologic disorders
- (2017) Reka Brubel et al. FERTILITY AND STERILITY
- Tim-3 and its role in regulating anti-tumor immunity
- (2017) Madhumita Das et al. IMMUNOLOGICAL REVIEWS
- Tim3+ Foxp3 + Treg Cells Are Potent Inhibitors of Effector T Cells and Are Suppressed in Rheumatoid Arthritis
- (2017) Huaqiang Sun et al. INFLAMMATION
- Tim3/Gal9 interactions between T cells and monocytes result in an immunosuppressive feedback loop that inhibits Th1 responses in osteosarcoma patients
- (2017) Xiuzhong Li et al. INTERNATIONAL IMMUNOPHARMACOLOGY
- Translational Implication of Galectin-9 in the Pathogenesis and Treatment of Viral Infection
- (2017) Jenn-Haung Lai et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- TIM-3 as a Target for Cancer Immunotherapy and Mechanisms of Action
- (2017) Wenwen Du et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Dectin 1 activation on macrophages by galectin 9 promotes pancreatic carcinoma and peritumoral immune tolerance
- (2017) Donnele Daley et al. NATURE MEDICINE
- The N- and C-terminal carbohydrate recognition domains of Haemonchus contortus galectin bind to distinct receptors of goat PBMC and contribute differently to its immunomodulatory functions in host-parasite interactions
- (2017) MingMin Lu et al. Parasites & Vectors
- Analysis of Tim-3 as a therapeutic target in prostate cancer
- (2017) Yongrui Piao et al. TUMOR BIOLOGY
- Tim-3-expressing macrophages are functionally suppressed and expanded in oral squamous cell carcinoma due to virus-induced Gal-9 expression
- (2017) Jianfeng Dong et al. TUMOR BIOLOGY
- A Co-Inhibitory Alliance in Myeloid Leukemia: TIM-3/Galectin-9 Complex as a New Target for Checkpoint Blockade Therapy
- (2017) M. Alper Kursunel et al. EBioMedicine
- The Tim-3-galectin-9 Secretory Pathway is Involved in the Immune Escape of Human Acute Myeloid Leukemia Cells
- (2017) Isabel Gonçalves Silva et al. EBioMedicine
- Diagnostic accuracy of cancer antigen 125 for endometriosis: a systematic review and meta-analysis
- (2016) M Hirsch et al. BJOG-AN INTERNATIONAL JOURNAL OF OBSTETRICS AND GYNAECOLOGY
- Discovery of TSR-022, a novel, potent anti-human TIM-3 therapeutic antibody
- (2016) A. Murtaza et al. EUROPEAN JOURNAL OF CANCER
- T-Cell Immunoglobulin– and Mucin-Domain–Containing Molecule 3 Signaling Blockade Improves Cell-Mediated Immunity Against Malaria
- (2016) Nan Hou et al. JOURNAL OF INFECTIOUS DISEASES
- Tim-3: Expression on immune cells and roles at the maternal-fetal interface
- (2016) Xiao-Hui Hu et al. JOURNAL OF REPRODUCTIVE IMMUNOLOGY
- Plasma levels of Galectin-9 reflect disease severity in malaria infection
- (2016) Bindongo P. P. Dembele et al. MALARIA JOURNAL
- Expression of the galectin-9-Tim-3 pathway in glioma tissues is associated with the clinical manifestations of glioma
- (2016) ZENGJIN LIU et al. Oncology Letters
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non–Small Cell Lung Cancer
- (2016) Valsamo Anagnostou et al. Cancer Discovery
- The Csk-Associated Adaptor PAG Inhibits Effector T Cell Activation in Cooperation with Phosphatase PTPN22 and Dok Adaptors
- (2016) Dominique Davidson et al. Cell Reports
- TIM-3 Regulates Distinct Functions in Macrophages
- (2016) Ranferi Ocaña-Guzman et al. Frontiers in Immunology
- The immune receptor Tim-3 acts as a trafficker in a Tim-3/galectin-9 autocrine loop in human myeloid leukemia cells
- (2016) Isabel Gonçalves Silva et al. OncoImmunology
- A TIM-3/Gal-9 Autocrine Stimulatory Loop Drives Self-Renewal of Human Myeloid Leukemia Stem Cells and Leukemic Progression
- (2015) Yoshikane Kikushige et al. Cell Stem Cell
- The Galectin-9/Tim-3 pathway is involved in the regulation of NK cell function at the maternal–fetal interface in early pregnancy
- (2015) Yan-Hong Li et al. Cellular & Molecular Immunology
- Blockade of PD1 and TIM3 Restores Innate and Adaptive Immunity in Patients With Acute Alcoholic Hepatitis
- (2015) Lee J.L. Markwick et al. GASTROENTEROLOGY
- Expression of immune checkpoint molecules of T cell immunoglobulin and mucin protein 3/galectin-9 for NK cell suppression in human gastrointestinal stromal tumors
- (2015) HIDEO KOMITA et al. ONCOLOGY REPORTS
- Increased Gal-9 and Tim-3 expressions during liver damage in a murine malarial model
- (2015) Siyu Xiao et al. PARASITOLOGY RESEARCH
- Upregulated Tim-3/galectin-9 expressions in acute lung injury in a murine malarial model
- (2015) Jinfeng Liu et al. PARASITOLOGY RESEARCH
- Apoptosis of tumor infiltrating effector TIM-3+CD8+ T cells in colon cancer
- (2015) Chiao-Wen Kang et al. Scientific Reports
- Tim-3 and Tim-4 as the potential targets for antitumor therapy
- (2015) Lin Cheng et al. Human Vaccines & Immunotherapeutics
- TIMgenes: a family of cell surface phosphatidylserine receptors that regulate innate and adaptive immunity
- (2015) Gordon J. Freeman et al. IMMUNOLOGICAL REVIEWS
- Galectin-9 controls the therapeutic activity of 4-1BB–targeting antibodies
- (2014) Shravan Madireddi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Lack of TIM-3 Immunoregulation in Multiple Sclerosis
- (2014) L. Yang et al. JOURNAL OF IMMUNOLOGY
- Galectin-9 Increases Tim-3+ Dendritic Cells and CD8+ T Cells and Enhances Antitumor Immunity via Galectin-9-Tim-3 Interactions
- (2014) K. Nagahara et al. JOURNAL OF IMMUNOLOGY
- CEACAM1 regulates TIM-3-mediated tolerance and exhaustion
- (2014) Yu-Hwa Huang et al. NATURE
- Correction: A Crucial Role for Kupffer Cell-Derived Galectin-9 in Regulation of T Cell Immunity in Hepatitis C Infection
- (2014) John A. Mengshol et al. PLoS One
- Liver-primed CD8+T cells suppress antiviral adaptive immunity through galectin-9-independent T-Cell immunoglobulin and mucin 3 engagement of high-mobility group box 1 in mice
- (2013) Joseph S. Dolina et al. HEPATOLOGY
- T Cell Ig Mucin-3 Promotes Homeostasis of Sepsis by Negatively Regulating the TLR Response
- (2013) X. Yang et al. JOURNAL OF IMMUNOLOGY
- T Cell Ig and Mucin Domain-Containing Protein 3 Is Recruited to the Immune Synapse, Disrupts Stable Synapse Formation, and Associates with Receptor Phosphatases
- (2013) K. L. Clayton et al. JOURNAL OF IMMUNOLOGY
- Dysregulated Tim-3 expression on natural killer cells is associated with increased Galectin-9 levels in HIV-1 infection
- (2013) Stephanie Jost et al. Retrovirology
- TIM3+FOXP3+regulatory T cells are tissue-specific promoters of T-cell dysfunction in cancer
- (2013) Kaori Sakuishi et al. OncoImmunology
- Tim-3 marks human natural killer cell maturation and suppresses cell-mediated cytotoxicity
- (2012) L. C. Ndhlovu et al. BLOOD
- Tim-3 is an inducible human natural killer cell receptor that enhances interferon gamma production in response to galectin-9
- (2012) M. K. Gleason et al. BLOOD
- Intestinal Tumorigenesis Initiated by Dedifferentiation and Acquisition of Stem-Cell-like Properties
- (2012) Sarah Schwitalla et al. CELL
- Tim-3, a negative regulator of anti-tumor immunity
- (2012) Ana Carrizosa Anderson CURRENT OPINION IN IMMUNOLOGY
- Tim-3/galectin-9 signaling pathway mediates T-cell dysfunction and predicts poor prognosis in patients with hepatitis B virus-associated hepatocellular carcinoma
- (2012) Hang Li et al. HEPATOLOGY
- Allograft rejection is restrained by short-lived TIM-3+PD-1+Foxp3+ Tregs
- (2012) Shipra Gupta et al. JOURNAL OF CLINICAL INVESTIGATION
- Tim-3 Pathway Controls Regulatory and Effector T Cell Balance during Hepatitis C Virus Infection
- (2012) J. P. Moorman et al. JOURNAL OF IMMUNOLOGY
- Tumor immunity times out: TIM-3 and HMGB1
- (2012) Daolin Tang et al. NATURE IMMUNOLOGY
- Tumor-infiltrating DCs suppress nucleic acid–mediated innate immune responses through interactions between the receptor TIM-3 and the alarmin HMGB1
- (2012) Shigeki Chiba et al. NATURE IMMUNOLOGY
- Bat3 promotes T cell responses and autoimmunity by repressing Tim-3–mediated cell death and exhaustion
- (2012) Manu Rangachari et al. NATURE MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Galectin-9 Controls CD40 Signaling through a Tim-3 Independent Mechanism and Redirects the Cytokine Profile of Pathogenic T Cells in Autoimmunity
- (2012) Gisela M. Vaitaitis et al. PLoS One
- Cell Surface Galectin-9 Expressing Th Cells Regulate Th17 and Foxp3+ Treg Development by Galectin-9 Secretion
- (2012) Souichi Oomizu et al. PLoS One
- Upregulation of the Tim-3/Galectin-9 Pathway of T Cell Exhaustion in Chronic Hepatitis B Virus Infection
- (2012) Gaia Nebbia et al. PLoS One
- Coexpression of Tim-3 and PD-1 identifies a CD8+ T-cell exhaustion phenotype in mice with disseminated acute myelogenous leukemia
- (2011) Q. Zhou et al. BLOOD
- Galectin-9 and T Cell Immunoglobulin Mucin-3 Pathway Is a Therapeutic Target for Type 1 Diabetes
- (2011) Motoko Kanzaki et al. ENDOCRINOLOGY
- Complement-mediated injury and protection of endothelium: Lessons from atypical haemolytic uraemic syndrome
- (2011) Heather Kerr et al. IMMUNOBIOLOGY
- Effective posttransplant antitumor immunity is associated with TLR-stimulating nucleic acid–immunoglobulin complexes in humans
- (2011) Yun Lin et al. JOURNAL OF CLINICAL INVESTIGATION
- Tim-3 regulates pro- and anti-inflammatory cytokine expression in human CD14+ monocytes
- (2011) Ying Zhang et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Phosphotyrosine-Dependent Coupling of Tim-3 to T-Cell Receptor Signaling Pathways
- (2011) J. Lee et al. MOLECULAR AND CELLULAR BIOLOGY
- Blockade of Tim-3 Pathway Ameliorates Interferon-γ Production from Hepatic CD8+ T Cells in a Mouse Model of Hepatitis B Virus Infection
- (2010) Ying Ju et al. Cellular & Molecular Immunology
- Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen–specific CD8+T cell dysfunction in melanoma patients
- (2010) Julien Fourcade et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Targeting Tim-3 and PD-1 pathways to reverse T cell exhaustion and restore anti-tumor immunity
- (2010) Kaori Sakuishi et al. JOURNAL OF EXPERIMENTAL MEDICINE
- T cell immunoglobulin- and mucin-domain-containing molecule-3 (Tim-3) mediates natural killer cell suppression in chronic hepatitis B
- (2010) Ying Ju et al. JOURNAL OF HEPATOLOGY
- T Cell/Transmembrane, Ig, and Mucin-3 Allelic Variants Differentially Recognize Phosphatidylserine and Mediate Phagocytosis of Apoptotic Cells
- (2010) Rosemarie H. DeKruyff et al. JOURNAL OF IMMUNOLOGY
- Genetics, pathogenesis and clinical interventions in type 1 diabetes
- (2010) Jeffrey A. Bluestone et al. NATURE
- Galectin-9/TIM-3 Interaction Regulates Virus-Specific Primary and Memory CD8+ T Cell Response
- (2010) Sharvan Sehrawat et al. PLoS Pathogens
- Tim-3 mediates phagocytosis of apoptotic cells and cross-presentation
- (2009) M. Nakayama et al. BLOOD
- Tim-3-Galectin-9 pathway involves the suppression induced by CD4+CD25+ regulatory T cells
- (2008) Feng Wang et al. IMMUNOBIOLOGY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now